Global Breakthrough Therapy (BT) Designation Market Analysis 2013-2018 and Forecast 2019-2024

April 2019 | 134 pages | ID: G0930E8AD50EN
99Strategy

Abstracts

SNAPSHOT

The global Breakthrough Therapy (BT) Designation market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Breakthrough Therapy (BT) Designation by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

• Oncology
• Infectious Diseases
• Rare Diseases
• Autoimmune Diseases
• Pulmonary Diseases
• Neurological Disorders
• Others

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

• Roche
• Abbvie
• Novartis International AG
• Janssen
• BMS
• Eli Lilly
• Gilead
• Sanofi
• Regeneron
• Acadia
• Boehringer Ingelheim
• Amgen
• AstraZeneca
• GlaxoSmithKline
• Vertex
• Alexion
• Merck
• Jazz Pharmaceuticals
• Exelixis
• Eisai
• Takeda
• Pfizer

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

• Hospital
• Clinic
• Research Institute
• Laboratories

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
• Asia-Pacific (China, India, Japan, Southeast Asia etc.)
• South America (Brazil, Argentina etc.)
• Middle East & Africa (Saudi Arabia, South Africa etc.)

Contents

1 INDUSTRY OVERVIEW

1.1 Breakthrough Therapy (BT) Designation Industry
  1.1.1 Overview
  1.1.2 Development of Breakthrough Therapy (BT) Designation
1.2 Market Segment
  1.2.1 Upstream
  1.2.2 Downstream
1.3 Cost Analysis

2 INDUSTRY ENVIRONMENT (PEST ANALYSIS)

2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology

3 BREAKTHROUGH THERAPY (BT) DESIGNATION MARKET BY TYPE

3.1 By Type
  3.1.1 Oncology
  3.1.2 Infectious Diseases
  3.1.3 Rare Diseases
  3.1.4 Autoimmune Diseases
  3.1.5 Pulmonary Diseases
  3.1.6 Neurological Disorders
  3.1.7 Others
3.2 Market Size
3.3 Market Forecast

4 MAJOR COMPANIES LIST

4.BREAKTHROUGH THERAPY (BT) DESIGNATION ROCHE (COMPANY PROFILE, SALES DATA ETC.)

4.2 Abbvie (Company Profile, Sales Data etc.)
4.3 Novartis International AG (Company Profile, Sales Data etc.)
4.4 Janssen (Company Profile, Sales Data etc.)
4.5 BMS (Company Profile, Sales Data etc.)
4.6 Eli Lilly (Company Profile, Sales Data etc.)
4.7 Gilead (Company Profile, Sales Data etc.)
4.8 Sanofi (Company Profile, Sales Data etc.)
4.9 Regeneron (Company Profile, Sales Data etc.)
4.10 Acadia (Company Profile, Sales Data etc.)
4.11 Boehringer Ingelheim (Company Profile, Sales Data etc.)
4.12 Amgen (Company Profile, Sales Data etc.)
4.13 AstraZeneca (Company Profile, Sales Data etc.)
4.14 GlaxoSmithKline (Company Profile, Sales Data etc.)
4.15 Vertex (Company Profile, Sales Data etc.)
4.16 Alexion (Company Profile, Sales Data etc.)
4.17 Merck (Company Profile, Sales Data etc.)
4.18 Jazz Pharmaceuticals (Company Profile, Sales Data etc.)
4.19 Exelixis (Company Profile, Sales Data etc.)
4.20 Eisai (Company Profile, Sales Data etc.)
4.21 Takeda (Company Profile, Sales Data etc.)
4.22 Pfizer (Company Profile, Sales Data etc.)

5 MARKET COMPETITION

5.1 Company Competition
5.2 Regional Market by Company

6 DEMAND BY END MARKET

6.1 Demand Situation
  6.1.1 Demand in Hospital
  6.1.2 Demand in Clinic
  6.1.3 Demand in Research Institute
  6.1.4 Demand in Laboratories
6.2 Regional Demand Comparison
6.3 Demand Forecast

7 REGION OPERATION

7.1 Regional Production
7.2 Regional Market
7.3 by Region
  7.3.1 North America
    7.3.1.1 Overview
    7.3.1.2 by Country (U.S., Canada, Mexico)
  7.3.2 Europe
    7.3.2.1 Overview
    7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  7.3.3 Asia-Pacific
    7.3.3.1 Overview
    7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  7.3.4 South America
    7.3.4.1 Overview
    7.3.4.2 by Country (Brazil, Argentina etc.)
  7.3.5 Middle East & Africa
    7.3.5.1 Overview
    7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
7.4 Regional Import & Export
7.5 Regional Forecast

8 MARKETING & PRICE

8.1 Price and Margin
  8.1.1 Price Trends
  8.1.2 Factors of Price Change
  8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel

9 RESEARCH CONCLUSION

List Of Tables

LIST OF TABLES

Table Upstream Segment of Breakthrough Therapy (BT) Designation
Table Application Segment of Breakthrough Therapy (BT) Designation
Table Global Breakthrough Therapy (BT) Designation Market 2013-2024, by Application, in USD Million
Table Major Company List of Oncology 
Table Major Company List of Infectious Diseases 
Table Major Company List of Rare Diseases 
Table Major Company List of Autoimmune Diseases 
Table Major Company List of Pulmonary Diseases 
Table Major Company List of Neurological Disorders 
Table Major Company List of Others
Table Global Breakthrough Therapy (BT) Designation Market 2013-2018, by Type, in USD Million
Table Global Breakthrough Therapy (BT) Designation Market 2013-2018, by Type, in Volume
Table Global Breakthrough Therapy (BT) Designation Market Forecast 2019-2024, by Type, in USD Million
Table Global Breakthrough Therapy (BT) Designation Market Forecast 2019-2024, by Type, in Volume
Table Roche  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Roche  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbvie  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Abbvie  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis International AG  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Novartis International AG  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Janssen  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Janssen  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BMS  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of BMS  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Eli Lilly  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Gilead  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Sanofi  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Regeneron  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Regeneron  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Acadia  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Acadia  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Boehringer Ingelheim  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Amgen  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of AstraZeneca  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of GlaxoSmithKline  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Vertex  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Vertex  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Alexion  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Alexion  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Merck  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Jazz Pharmaceuticals  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Jazz Pharmaceuticals  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Exelixis  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Exelixis  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eisai  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Eisai  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda  Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Takeda  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Breakthrough Therapy (BT) Designation Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Breakthrough Therapy (BT) Designation Sales Revenue 2013-2018, by Company, in USD Million
Table Global Breakthrough Therapy (BT) Designation Sales Revenue Share, by Company, in USD Million
Table Global Breakthrough Therapy (BT) Designation Sales Volume 2013-2018, by Company, in Volume
Table Global Breakthrough Therapy (BT) Designation Sales Volume Share 2013-2018, by Company, in Volume
Table Major Consumers List and Overview
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Breakthrough Therapy (BT) Designation Demand Forecast 2019-2024, by Application, in USD Million
Table Breakthrough Therapy (BT) Designation Demand Forecast 2019-2024, by Application, in Volume
Table Breakthrough Therapy (BT) Designation Production 2013-2018, by Region, in USD Million
Table Breakthrough Therapy (BT) Designation Production 2013-2018, by Region, in Volume
Table Global Breakthrough Therapy (BT) Designation Market 2013-2018, by Region, in USD Million
Table Global Breakthrough Therapy (BT) Designation Market Share 2013-2018, by Region, in USD Million
Table Global Breakthrough Therapy (BT) Designation Market 2013-2018, by Region, in Volume
Table Global Breakthrough Therapy (BT) Designation Market Share 2013-2018, by Region, in Volume
Table North America Breakthrough Therapy (BT) Designation Market Size 2013-2018, by Country, in USD Million
Table North America Breakthrough Therapy (BT) Designation Market Size 2013-2018, by Country, in Volume
Table Europe Breakthrough Therapy (BT) Designation Market Size 2013-2018, by Country, in USD Million
Table Europe Breakthrough Therapy (BT) Designation Market Size 2013-2018, by Country, in Volume
Table Asia-Pacific Breakthrough Therapy (BT) Designation Market Size 2013-2018, by Country, in USD Million
Table Asia-Pacific Breakthrough Therapy (BT) Designation Market Size 2013-2018, by Country, in Volume
Table South America Breakthrough Therapy (BT) Designation Market Size 2013-2018, by Country, in USD Million
Table South America Breakthrough Therapy (BT) Designation Market Size 2013-2018, by Country, in Volume
Table Middle East & Africa Breakthrough Therapy (BT) Designation Market Size 2013-2018, by Country, in USD Million
Table Middle East & Africa Breakthrough Therapy (BT) Designation Market Size 2013-2018, by Country, in Volume
Table Breakthrough Therapy (BT) Designation Market Forecast 2019-2024, by Region, in USD Million
Table Breakthrough Therapy (BT) Designation Market Forecast 2019-2024, by Region, in Volume
Table Price Factors List

List Of Figures

LIST OF FIGURES

Figure Global Breakthrough Therapy (BT) Designation Market Growth 2013-2018, by Type, in USD Million
Figure Global Breakthrough Therapy (BT) Designation Market Growth 2013-2018, by Type, in Volume
Figure North America Breakthrough Therapy (BT) Designation Market Concentration, in 2018
Figure Europe Breakthrough Therapy (BT) Designation Market Market Concentration, in 2018
Figure Asia-Pacific Breakthrough Therapy (BT) Designation MMarket Concentration, in 2018
Figure South America Breakthrough Therapy (BT) Designation Market Concentration, in 2018
Figure Middle East & Africa Breakthrough Therapy (BT) Designation Market Concentration, in 2018
Figure Breakthrough Therapy (BT) Designation Demand in Hospital , 2013-2018, in USD Million
Figure Breakthrough Therapy (BT) Designation Demand in Hospital , 2013-2018, in Volume
Figure Breakthrough Therapy (BT) Designation Demand in Clinic , 2013-2018, in USD Million
Figure Breakthrough Therapy (BT) Designation Demand in Clinic , 2013-2018, in Volume
Figure Breakthrough Therapy (BT) Designation Demand in Research Institute , 2013-2018, in USD Million
Figure Breakthrough Therapy (BT) Designation Demand in Research Institute , 2013-2018, in Volume
Figure Breakthrough Therapy (BT) Designation Demand in Laboratories, 2013-2018, in USD Million
Figure Breakthrough Therapy (BT) Designation Demand in Laboratories, 2013-2018, in Volume
Figure North America Breakthrough Therapy (BT) Designation Market Size and Growth 2013-2018, in USD Million
Figure North America Breakthrough Therapy (BT) Designation Market Size and Growth 2013-2018, in Volume
Figure Europe Breakthrough Therapy (BT) Designation Market Size and Growth 2013-2018, in USD Million
Figure Europe Breakthrough Therapy (BT) Designation Market Size and Growth 2013-2018, in Volume
Figure Asia-Pacific Breakthrough Therapy (BT) Designation Market Size and Growth 2013-2018, in USD Million
Figure Asia-Pacific Breakthrough Therapy (BT) Designation Market Size and Growth 2013-2018, in Volume
Figure South America Breakthrough Therapy (BT) Designation Market Size and Growth 2013-2018, in USD Million
Figure South America Breakthrough Therapy (BT) Designation Market Size and Growth 2013-2018, in Volume
Figure Middle East & Africa Breakthrough Therapy (BT) Designation Market Size and Growth 2013-2018, in USD Million
Figure Middle East & Africa Breakthrough Therapy (BT) Designation Market Size and Growth 2013-2018, in Volume
Figure Marketing Channels Overview